SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1.95 |
Enterprise Value ($M) | 3.09 |
Book Value ($M) | -0.95 |
Book Value / Share | -1.12 |
Price / Book | -2.05 |
NCAV ($M) | -2.54 |
NCAV / Share | -2.98 |
Price / NCAV | -0.77 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -18.98 |
Return on Assets (ROA) | -1.19 |
Return on Equity (ROE) | -2.42 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.45 |
Current Ratio | 0.45 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1.85 |
Assets | 3.44 |
Liabilities | 4.40 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -13.48 |
Net Income | -19.94 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -10.92 |
Cash from Investing | 0.00 |
Cash from Financing | 5.91 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
4,569 | 29,648 | 15.41 | |
5,161 | 68,774 | 7.50 | |
16,548 | 77,196 | 21.44 | |
42,857 | 145,665 | 29.42 | |
22,653 | 133,089 | 17.02 | |
(click for more detail) |
Similar Companies | |
---|---|
ARTL – Artelo Biosciences, Inc. | ASNS – Actelis Networks, Inc. |
ASRT – Assertio Holdings, Inc. | ATOS – Atossa Therapeutics, Inc. |
ATXI – Avenue Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io